DEPLOYDatabase

Partnership

Parker Hannifin Indego x Vanderbilt University

Vanderbilt University researchers designed the Indego powered lower-limb exoskeleton and partnered with Parker Hannifin to commercialize it. The partnership resulted in FDA clearance for clinical and personal use in 2016 for patients with spinal cord injuries and stroke hemiplegia.

development · Concluded · operating

Track Parker Hannifin Indego x Vanderbilt University

Machine-readable surfaces

ada14013-b162-4f0f-ba4d-765997d79365
Type
development
Status
Concludedoperating

Who’s involved

Parker Hannifin Indegomanufacturer

Parker Hannifin Indego was a division of Parker Hannifin that developed the Indego powered lower-limb exoskeleton for individuals with spinal cord injuries. Licensed from [Vanderbilt university](/companies/vanderbilt-university) in 2012, the device received FDA clearance in March 2016 and CE Mark in November 2015, enabling users to stand and walk for up to four hours. Parker Hannifin sold the Indego business to Ekso Bionics in December 2022 for $10 million, exiting the exoskeleton market.

HQCleveland, OH, USA2 partnerships

Off-registry parties

  • Vanderbilt University · co developer

Related partnerships

Other deals between the same parties

Recent partnerships of the same kind

Sources (1)

  1. https://news.vumc.org/2016/03/10/fda-approves-vanderbilt-designed-indego-exoskeleton-for-clinical-and-personal-use/

Deploy Watch

Track this partnership.

We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.